Skip to main content
Fig. 3 | Nutrition & Metabolism

Fig. 3

From: Indirubin, a small molecular deriving from connectivity map (CMAP) screening, ameliorates obesity-induced metabolic dysfunction by enhancing brown adipose thermogenesis and white adipose browning

Fig. 3

Indirubin treatment improves glucose tolerance and insulin sensitivity in HFD-induced obese mice. a Blood concentrations of glucose in mice fasted 16 h after 6-week treatment with either vehicle or indirubin. b Blood concentrations of insulin in mice fasted overnight after 8-week treatment with either vehicle or indirubin. c Glucose tolerance tests (GTT) performed in mice (i.p. injection of glucose, 1.5 g /kg) fasted 16 h after 6-week treatment with indirubin or vehicle. (n = 6 for each treatment). d Area under curve (AUC) for glucose based on data in c. e Insulin tolerance tests (ITT) performed in mice (i.p. injection of insulin, 0.75 U /kg) fasted 4 h after 7-week treatment with indirubin or vehicle. f Area under curve (AUC) for glucose based on data in e. Data are presented as mean ± SD (n = 6 in each group). #p < 0.05, ##p < 0.01, ###p < 0.001 compared with NCD + vehicle group; *p < 0.05, **p < 0.01, ***p < 0.01 compared with HFD + vehicle group

Back to article page

Nutrition & Metabolism

ISSN: 1743-7075

Contact us